Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of ABT-414 in Participants With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification

ClinicalTrials.gov ID: NCT02573324

Public ClinicalTrials.gov record NCT02573324. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 12:47 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Placebo Controlled Phase 3 Study of ABT-414 With Concurrent Chemoradiation and Adjuvant Temozolomide in Subjects With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) Amplification (Intellance1)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study seeks to determine whether the addition of ABT-414 to concomitant radiotherapy and temozolomide (TMZ) followed by combination of ABT-414 with adjuvant TMZ prolongs overall survival (OS) among participants with newly diagnosed glioblastoma (GBM) with epidermal growth factor receptor (EGFR) amplification. In addition, there is a Phase 1, open-label, multicenter sub-study to assess the pharmacokinetics, safety and tolerability of ABT-414 in participants with newly diagnosed EGFR-amplified GBM who have mild or moderate hepatic impairment.

Study identification

NCT ID
NCT02573324
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AbbVie
Industry
Enrollment
691 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 99 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 4, 2015 (Actual)
Primary completion
Apr 4, 2022 (Actual)
Completion
Apr 4, 2022 (Actual)
Last update posted
May 11, 2023

2015 – 2022

United States locations

U.S. sites
68
U.S. states
29
U.S. cities
55
Facility City State ZIP Site status
St. Josephs Hospital and Med Center /ID# 144149 Phoenix Arizona 85013 —
Highlands Oncology Group, PA /ID# 142050 Springdale Arkansas 72762 —
University of Southern California /ID# 147543 Los Angeles California 90033 —
University of California, Los Angeles /ID# 149239 Los Angeles California 90095 —
Sharp Memorial Hospital /ID# 148193 San Diego California 92123 —
Univ California, San Francisco /ID# 145889 San Francisco California 94143-2204 —
Duplicate_St. John's Health Center /ID# 148192 Santa Monica California 90404 —
Cedars-Sinai Medical Center-West Hollywood /ID# 148472 West Hollywood California 90048 —
Univ of Colorado Cancer Center /ID# 148194 Aurora Colorado 80045 —
Associated Neurologists of Sou /ID# 147701 Fairfield Connecticut 06824 —
Yale University /ID# 144170 New Haven Connecticut 06510 —
Christiana Care Health Service /ID# 144127 Newark Delaware 19713 —
Boca Raton Regional Hospital /ID# 163659 Boca Raton Florida 33486 —
Holy Cross Hospital /ID# 156764 Fort Lauderdale Florida 33308 —
Baptist Hospital Miami /ID# 152451 Miami Florida 33176 —
Advent Health /ID# 144128 Orlando Florida 32803 —
Moffitt Cancer Center /ID# 144130 Tampa Florida 33612-9416 —
Piedmont Hospital /ID# 145892 Atlanta Georgia 30309 —
Emory Midtown Infectious Disease Clinic /ID# 144015 Atlanta Georgia 30322 —
Northwestern University Feinberg School of Medicine /ID# 147895 Chicago Illinois 60611-2927 —
The University of Chicago Medical Center /ID# 144158 Chicago Illinois 60637-1443 —
NorthShore University HealthSystem /ID# 144017 Evanston Illinois 60201 —
Northwestern Medicine Cancer Center - Warrenville /ID# 148476 Warrenville Illinois 60555 —
Parkview Research Ctr, Hosp /ID# 144150 Fort Wayne Indiana 46805 —
Univ Kansas Cancer Ctr - Overl /ID# 145895 Westwood Kansas 66205-2003 —
Maine Medical Partners Neurolo /ID# 160864 Scarborough Maine 04074 —
Tufts Medical Center /ID# 145897 Boston Massachusetts 02111-1552 —
Massachusetts General Hospital /ID# 144145 Boston Massachusetts 02114 —
Dana-Farber Cancer Institute /ID# 148475 Boston Massachusetts 02215 —
Wayne State University /ID# 145890 Detroit Michigan 48201-2013 —
Henry Ford Health System /ID# 145896 Detroit Michigan 48202 —
Duplicate_St. Joseph Mercy Hospital /ID# 144143 Ypsilanti Michigan 48197 —
Mmcorc /Id# 144146 Saint Louis Park Minnesota 55416 —
Washington University-School of Medicine /ID# 144174 St Louis Missouri 63110 —
Nebraska Methodist Hospital /ID# 144140 Omaha Nebraska 68114 —
University of Nebraska Medical Center /ID# 145899 Omaha Nebraska 68198 —
MD Anderson Cancer Center at Cooper - Camden /ID# 145891 Camden New Jersey 08103 —
Rutgers Cancer Institute of New Jersey /ID# 148190 New Brunswick New Jersey 08901 —
Columbia University Medical Center /ID# 144020 New York New York 10032-3729 —
University of Rochester Medical Center /ID# 144166 Rochester New York 14642 —
Levine Cancer Ins, Carolina Me /ID# 144124 Charlotte North Carolina 28204 —
University of Cincinnati /ID# 144164 Cincinnati Ohio 45267-0585 —
Duplicate_Univ Hosp Cleveland /ID# 144153 Cleveland Ohio 44106 —
Cleveland Clinic Main Campus /ID# 144023 Cleveland Ohio 44195 —
The Ohio State University /ID# 144016 Columbus Ohio 43210 —
University of Toledo /ID# 156763 Toledo Ohio 43614 —
Univ Oklahoma HSC /ID# 144161 Oklahoma City Oklahoma 73104 —
St. Luke's Hospital /ID# 148191 Bethlehem Pennsylvania 18017 —
Penn State University and Milton S. Hershey Medical Center /ID# 147525 Hershey Pennsylvania 17033 —
University of Pennsylvania /ID# 157623 Philadelphia Pennsylvania 19104-5502 —
Thomas Jefferson University /ID# 144191 Philadelphia Pennsylvania 19107-4414 —
Fox Chase Cancer Center /ID# 145893 Philadelphia Pennsylvania 19111 —
Allegheny General Hospital /ID# 144126 Pittsburgh Pennsylvania 15212 —
University of Pennsylvania Medical Center - Shadyside /ID# 144159 Pittsburgh Pennsylvania 15232 —
Medical University of South Carolina /ID# 144141 Charleston South Carolina 29425 —
Austin Cancer Centers /ID# 151061 Austin Texas 78758 —
Baylor Sammons Cancer Center /ID# 155542 Dallas Texas 75246 —
The University of Texas Health Science Center at Houston /ID# 144013 Houston Texas 77030 —
University of Texas MD Anderson Cancer Center /ID# 144018 Houston Texas 77030 —
Duplicate_Scott and White Medical Center /ID# 160743 Temple Texas 76508 —
Intermountain Medical Center /ID# 144142 Murray Utah 84107-5701 —
University of Utah /ID# 144160 Salt Lake City Utah 84112-5500 —
Inova Health System /ID# 152956 Falls Church Virginia 22042 —
Virginia Commonwealth University Medical Center Main Hospital /ID# 149014 Richmond Virginia 23219 —
Virginia Mason Medical Center /ID# 144022 Seattle Washington 98101 —
University of Washington /ID# 144162 Seattle Washington 98109 —
Univ of Wisconsin Hosp/Clinics /ID# 144167 Madison Wisconsin 53792-0001 —
Froedtert Memorial Lutheran Hospital /ID# 144139 Milwaukee Wisconsin 53226-3522 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 144 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02573324, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 11, 2023 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02573324 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →